184
Views
24
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection

, , , &
Pages 596-603 | Received 01 Oct 2006, Published online: 08 Jul 2009

References

  • Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, et al. CD14 is a pattern recognition receptor. Immunity 1994; 1: 509–16
  • Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1–5
  • Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991; 147: 1567–74
  • Lin RY, Astiz ME, Saxon JC, Rackow EC. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 1993; 104: 847–53
  • Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 1481–3
  • Heinzelmann M, Mercer-Jones M, Cheadle WG, Polk HC, Jr. CD14 expression in injured patients correlates with outcome. Ann Surg 1996; 224: 91–6
  • Blondin C, Le Dur A, Cholley B, Caroff M, Haeffner-Cavaillon N. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes. Eur J Immunol 1997; 27: 3303–9
  • Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A 1993; 90: 2744–8
  • Wenisch C, Wenisch H, Parschalk B, Vanijanonta S, Burgmann H, Exner M, et al. Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clin Exp Immunol 1996; 105: 74–8
  • Landmann R, Reber AM, Sansano S, Zimmerli W. Function of soluble CD14 in serum from patients with septic shock. J Infect Dis 1996; 173: 661–8
  • Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, Glauser MP, et al. Increased circulating soluble CD14 is associated with high mortality in Gram-negative septic shock. J Infect Dis 1995; 171: 639–44
  • Burgmann H, Winkler S, Locker GJ, Presterl E, Laczika K, Staudinger T, et al. Increased serum concentration of soluble CD14 is a prognostic marker in Gram-positive sepsis. Clin Immunol Immunopathol 1996; 80: 307–10
  • Aalto H, Takala A, Kautiainen H, Repo H. Peripheral blood phagocyte CD14 and CD11b expression on admission to hospital in relation to mortality among patients with community acquired infection. Inflamm Res 2005; 54: 428–34
  • Gluck T, Silver J, Epstein M, Cao P, Farber B, Goyert SM. Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis. Eur J Med Res 2001; 6: 351–8
  • Serke S, van Lessen A, Huhn D. Quantitative fluorescence flow cytometry: a comparison of the 3 techniques for direct and indirect immunofluorescence. Cytometry 1998; 33: 179–87
  • Repo H, Jansson SE, Leirisalo-Repo M. Flow cytometric determination of CD11b up-regulation in vivo. J Immunol Methods 1993; 164: 193–202
  • Marchant A, Duchow J, Delville JP, Goldman M. Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood. Eur J Immunol 1992; 22: 1663–5
  • Sucic M, Kolevska T, Kopjar B, Kosanovic M, Drobnjak M, Zalud I, et al. Accuracy of routine flow-cytometric bitmap selection for 3 leukocyte populations. Cytometry 1989; 10: 442–7
  • Su GL, Dorko K, Strom SC, Nussler AK, Wang SC. CD14 expression and production by human hepatocytes. J Hepatol 1999; 31: 435–42
  • Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004; 172: 4470–9
  • Dziarski R, Viriyakosol S, Kirkland TN, Gupta D. Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide. Infect Immun 2000; 68: 5254–60
  • Yu B, Hailman E, Wright SD. Lipopolysaccharide binding protein and soluble CD14 catalyse exchange of phospholipids. J Clin Invest 1997; 99: 315–24
  • Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3: 678–81
  • Wolk K, Docke WD, Von Baehr V, Volk HD, Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000; 96: 218–23
  • Piani A, Hossle JP, Birchler T, Siegrist CA, Heumann D, Davies G, et al. Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness. Eur J Immunol 2000; 30: 3140–6
  • Rosenbloom AJ, Linden PK, Dorrance A, Penkosky N, Cohen-Melamed MH, Pinsky MR. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in non-neutropenic patients. Chest 2005; 127: 2139–50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.